<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1104760</article-id><article-id pub-id-type="publisher-id">OALibJ-86642</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Infection with Hepatitis B and C Virus in the Democratic Republic of Congo: A Public Health Problem
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ben</surname><given-names>Ilunga Bulanda</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Berry</surname><given-names>Ikolango Bongenya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean-Yves</surname><given-names>Debels Kabasele</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Médard</surname><given-names>Omakoy Okonda</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Divine</surname><given-names>Chuga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Christian</surname><given-names>Tshisumbu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elvis</surname><given-names>Tshunza Kateba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Erick</surname><given-names>Ntambwe Kamangu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Molecular Biochemistry Service, Department of Basic Sciences, Faculty of Medicine, University of Kinshasa (UNIKIN), 
Kinshasa, Democratic Republic of Congo</addr-line></aff><aff id="aff1"><addr-line>“HIV/AIDS Focus” Research Group, Kinshasa, Democratic Republic of Congo</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>08</month><year>2018</year></pub-date><volume>05</volume><issue>08</issue><fpage>1</fpage><lpage>6</lpage><history><date date-type="received"><day>6,</day>	<month>July</month>	<year>2018</year></date><date date-type="rev-recd"><day>11,</day>	<month>August</month>	<year>2018</year>	</date><date date-type="accepted"><day>14,</day>	<month>August</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Viral hepatitis represents a major public health burden with more than 375 million people with chronic hepatitis B infection and 130 to 150 million with hepatitis C for 2016. Sub-Saharan Africa has the heaviest burden of the epidemic. Objective: The objective of this review is to present the characteristics of hepatitis B and C infections (HBV and HCV), present the synthesis and estimate its magnitude in the Democratic Republic of Congo for the last 20 years. Methods: This work consisted in cataloging the various published articles and abstracts presented in scientific conferences having as subject
   of interest the infection with viral hepatitis B and C in the DRC. The search for these published works on different infections was done on the internet from different search engines. The research was limited to published works and abstracts presented over the last 20 years. Pediatric studies, studies in patients with renal or hepatic infections or without original data were not included in this review. Results: According to the various works published and presented in conference since 1997, the populations targeted for the investigations on the hepatitis B and C infections are the poly-transfused, the blood donors and the People Living with HIV. Seven (7) works have been documented for the DRC meeting the various selection criteria. In 1999, the carriage of HBV infection was 9.2% in Kinshasa. In 2000, the carriage of HBV was 5.9% while that of HCV was 4.8% in Kinshasa. In 2001, the portage of HCV was 5.0% in Kinshasa. In 2004, the prevalence of HBs antigen was 5.4% in Kisangani. In 2008, the prevalence of HBV and HCV was 8% and 4% respectively in Bukavu. In 2008, seroprevalences of HBV and HCV were respectively 4.2% and 3.8% in Bukavu. In 2012 and 2013, prevalence of HCV was 5.8% and 5.2% respectively in Kinshasa. Conclusions: Although often asymptomatic, viral hepatitis B and C are a public health problem for the Democratic Republic of Congo. The prevalence of these viral infections is far superior to that of HIV infection in Blood Transfusion Centers across the country.
 
</p></abstract><kwd-group><kwd>Hepatitis B</kwd><kwd> Hepatitis C</kwd><kwd> Kinshasa</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hepatitis B and C viruses (HBV and HCV) are different viruses that have the same modes of transmission, the same targets and present the same symptoms. HBV is a DNA virus belonging to the family of hepadnaviridae of the genus orthohepadnavirus [<xref ref-type="bibr" rid="scirp.86642-ref1">1</xref>] . In contrast, HCV is an RNA virus of the flaviridae family of the genus hepacivirus [<xref ref-type="bibr" rid="scirp.86642-ref1">1</xref>] .</p><p>Viral hepatitis represents a major public health burden with more than 375 million people with chronic hepatitis B infection and 130 to 150 million with hepatitis C for 2016, of which 4 to 5 million infected with the Human Immunodeficiency Virus (HIV) and about one million deaths per year [<xref ref-type="bibr" rid="scirp.86642-ref1">1</xref>] . Sub-Saharan Africa bears the greatest burden of the epidemic.</p><p>For HBV, transmission is mainly parenteral, sexual and maternofetal [<xref ref-type="bibr" rid="scirp.86642-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref3">3</xref>] . It is linked to parenteral injections (blood transfusions, intravenous drug use, hemodialysis), sex with people infected with the virus, transplacental transit or delivery (vertical transmission) [<xref ref-type="bibr" rid="scirp.86642-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref4">4</xref>] . Immunocompetent adults have more than 90% spontaneous HBV clearance capacity. Likewise for HCV, transmission is mainly parenteral [<xref ref-type="bibr" rid="scirp.86642-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref5">5</xref>] .</p><p>People infected with HBV and HCV do not usually feel sick and recover completely. Those who are symptomatic have symptoms similar to the common flu (fever, headaches, etc.) as well as stomachaches, diarrhea and jaundice that normally begin 1 - 3 months after the virus enters the body. Ten percent (10%) of adults with acute hepatitis B and 80% of those with hepatitis C develop chronic infection that may result in cirrhosis and/or liver cancer later in the patient [<xref ref-type="bibr" rid="scirp.86642-ref1">1</xref>] .</p><p>For several years, different works have made it possible to better understand and specify the different profiles as well as the carriage of hepatitis infection in the Democratic Republic of Congo (DRC) among transfused persons, blood donors and People Living with HIV (PLHIV). The objective of this review is to present the characteristics of hepatitis B and C infections (HBV and HCV), to present the synthesis and to estimate the extent of this infection in the DRC for the last 20 years.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Literature Search</title><p>This work consisted in cataloging the various published articles and abstracts presented in scientific conferences having as subject of interest the viral hepatitis B and C infection in the Democratic Republic of Congo (DRC). The search for these published works on the different infections was made from the following search engines on the internet: 1) Cochrane library; 2) Google scholar; 3) MEDLINE/PubMed; 4) POPLINE electronic database of published scientific documents; 5) Public access data on conference papers; 6) Scientific report published on the internet. This online search was based on the following keywords: “HBV, HCV, DRC”, “hepatitis, and Democratic Republic of Congo”.</p></sec><sec id="s2_2"><title>2.2. Criteria for Inclusion and Non-Inclusion</title><p>The research was limited to published works and abstracts presented over the last 20 years (1997 to 2017). The manuscripts were retained according to the relevance of the methodology of the different works, the results and the representability of the samples. The socio-demographic information of the sample, the methods of measurement and the objectives were considered in the evaluation of the articles. Re-reading of the various manuscripts excluded articles and abstracts that did not directly concern hepatitis B and C in the DRC. Pediatric studies, studies in patients with renal or hepatic infections or without original data were not included in this review.</p></sec></sec><sec id="s3"><title>3. Results and Discussions</title><p>The objective of this literature review was to present the carriage and extent of hepatitis B and C infection (HBV and HCV) in the Democratic Republic of Congo (DRC) compared to the different data published over the last 20 years. Seven (7) works have been documented for the DRC particularly meeting the different selection criteria. According to the various works published and presented in conference since 1997, the populations targeted for the surveillance surveys on the hepatitis B and C infections are the poly-transfused, the blood donors and the People Living with HIV (PLHIV). All data are presented in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>In 1999, Mbendi NC et al. reported a prevalence of HBV infection of 9.2% using 7277 sera from volunteers who agreed to donate blood for the first time (first time blood donor) in the eastern part of the city of Kinshasa [<xref ref-type="bibr" rid="scirp.86642-ref6">6</xref>] . The average age was 32.01 &#177; 9.23 years with extremes ranging from 10 to 79 years. The most represented age group in this cohort was 30 to 39 years, followed by 25 to 29 years. The male patients dominated in the total population of 77.9% [<xref ref-type="bibr" rid="scirp.86642-ref6">6</xref>] . This work was carried out in collaboration with the following hospitals: University Clinics of Kinshasa (UCK), Kingasani Hospital Center (CHK), Kinshasa</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Prevalence of Hepatitis infections per studies in DRC</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Study</th><th align="center" valign="middle" >Years</th><th align="center" valign="middle" >City</th><th align="center" valign="middle" >Total Number of population</th><th align="center" valign="middle" >Number of females</th><th align="center" valign="middle" >Prevalence of HBV</th><th align="center" valign="middle" >Prevalence of HCV</th></tr></thead><tr><td align="center" valign="middle" >Mbendi NC et al. [<xref ref-type="bibr" rid="scirp.86642-ref6">6</xref>]</td><td align="center" valign="middle" >1999</td><td align="center" valign="middle" >Kinshasa</td><td align="center" valign="middle" >7277</td><td align="center" valign="middle" >1608 (22.1%)</td><td align="center" valign="middle" >9.2%</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Baleka et al. [<xref ref-type="bibr" rid="scirp.86642-ref7">7</xref>]</td><td align="center" valign="middle" >2000</td><td align="center" valign="middle" >Kinshasa</td><td align="center" valign="middle" >373</td><td align="center" valign="middle" >62 (16.6%)</td><td align="center" valign="middle" >5.9%</td><td align="center" valign="middle" >4.8%</td></tr><tr><td align="center" valign="middle" >Laurent C et al. [<xref ref-type="bibr" rid="scirp.86642-ref8">8</xref>]</td><td align="center" valign="middle" >2001</td><td align="center" valign="middle" >Kinshasa</td><td align="center" valign="middle" >1806</td><td align="center" valign="middle" >1806 (100%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >5.0%</td></tr><tr><td align="center" valign="middle" >Batina A et al. [<xref ref-type="bibr" rid="scirp.86642-ref9">9</xref>]</td><td align="center" valign="middle" >2003-2004</td><td align="center" valign="middle" >Kisangani</td><td align="center" valign="middle" >3390</td><td align="center" valign="middle" >1843 (54.4%)</td><td align="center" valign="middle" >5.4%</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Kabinda JM et al. [<xref ref-type="bibr" rid="scirp.86642-ref10">10</xref>]</td><td align="center" valign="middle" >2008</td><td align="center" valign="middle" >Bukavu</td><td align="center" valign="middle" >211 VIH− 209 VIH+</td><td align="center" valign="middle" >142 (67.2%) 141 (67.4%)</td><td align="center" valign="middle" >8% 8%</td><td align="center" valign="middle" >4% 10%</td></tr><tr><td align="center" valign="middle" >Kabinda JM et al. [<xref ref-type="bibr" rid="scirp.86642-ref11">11</xref>]</td><td align="center" valign="middle" >2012</td><td align="center" valign="middle" >Bukavu</td><td align="center" valign="middle" >1079</td><td align="center" valign="middle" >298 (27.6%)</td><td align="center" valign="middle" >4.2%</td><td align="center" valign="middle" >3.88%</td></tr><tr><td align="center" valign="middle" >Kamangu NE et al. [<xref ref-type="bibr" rid="scirp.86642-ref12">12</xref>]</td><td align="center" valign="middle" >2012 2013</td><td align="center" valign="middle" >Kinshasa</td><td align="center" valign="middle" >5271 5040</td><td align="center" valign="middle" >1467 (14.2%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >5.8% 5.2%</td></tr></tbody></table></table-wrap><p>Kimbanguist Hospital (HKK) and N’djili Hospital (HND) [<xref ref-type="bibr" rid="scirp.86642-ref6">6</xref>] .</p><p>In 2000, Baleka F et al. worked on 373 blood donor sera from blood transfusion centers at Kinshasa General Hospital (KGH), Kimbanseke Kimbanguist Hospital, Kintambo Hospital, Bondeko Clinic and Ngaliema Clinic, all in the city of Kinshasa [<xref ref-type="bibr" rid="scirp.86642-ref7">7</xref>] . HBV carriage was 5.9% while HCV carriage was 4.8% in this donor population. The most represented age group is that of 21 to 39 years followed by that of 40 to 49 years for both viral infections [<xref ref-type="bibr" rid="scirp.86642-ref7">7</xref>] . Donors were predominantly male dominated with 311 donors (83.4%). The median age of the population was 36 years old. The majority of donors (92.5%) were family donors [<xref ref-type="bibr" rid="scirp.86642-ref7">7</xref>] .</p><p>In 2001, Laurent C et al. presented a carriage of 5.0% for HCV in an all-female population of 1806 HIV-negative patients [<xref ref-type="bibr" rid="scirp.86642-ref8">8</xref>] . The population consisted of professional sex workers followed in appropriate treatment centers and pregnant women followed in prenatal consultation structures accredited by the health system of Kinshasa [<xref ref-type="bibr" rid="scirp.86642-ref8">8</xref>] .</p><p>In Kisangani, capital of Orientale Province, Batina A et al. published a portage of HBs antigen in the period from 2003 to 2004 of 5.4% in a population of 3390 blood donors at the Provincial Blood Transfusion Center (PBTC) of Kisangani [<xref ref-type="bibr" rid="scirp.86642-ref9">9</xref>] . The average age of donors was 35 &#177; 1.24 years, and females (54.4%) dominated the donor population [<xref ref-type="bibr" rid="scirp.86642-ref9">9</xref>] . The majority (69.2%) of blood donors were family donors followed by volunteer donors (29.2%) [<xref ref-type="bibr" rid="scirp.86642-ref9">9</xref>] .</p><p>In Bukavu, capital of South Kivu province, Kabinda JM et al. reported hepatitis B and C prevalences of 8% and 10% respectively in a population of 209 immunocompromised patients (HIV positive) and 8% and 4% in a population of 211 immunocompetent controls (HIV-negative) in 2008 [<xref ref-type="bibr" rid="scirp.86642-ref10">10</xref>] . The mean ages of the 2 populations were 36.7 &#177; 11.7 years and 37.3 &#177; 11.3 years, respectively, for immunocompromised and immunocompetent patients. The most represented age group was 21 to 39 years in both populations [<xref ref-type="bibr" rid="scirp.86642-ref10">10</xref>] . Females were more represented in both populations; 67.2% in the immunocompetent group and 67.4% in the immunocompromised group [<xref ref-type="bibr" rid="scirp.86642-ref10">10</xref>] . The immunocompetent group consisted of 143 (67.8%) volunteer blood donors and 68 (32.2%) patients hospitalized in the Internal Medicine Department of the Bukavu Provincial Hospital [<xref ref-type="bibr" rid="scirp.86642-ref10">10</xref>] .</p><p>In 2014, Kabinda JM et al. published a seroprevalence of hepatitis B and C respectively of 4.2% and 3.8% on a population of 1079 voluntary unpaid blood donors in Bukavu [<xref ref-type="bibr" rid="scirp.86642-ref11">11</xref>] . The most represented age group was under 30 years in the range of 18 to 60 years and a median age of 26 years. The male sex (72.4%) was dominant in the surveyed population [<xref ref-type="bibr" rid="scirp.86642-ref11">11</xref>] . Just over half, 54.5%, consisted of new blood donors [<xref ref-type="bibr" rid="scirp.86642-ref11">11</xref>] . According to the study, for the city of Bukavu, the profile of the donor at risk is a married male blood donor from rural areas under the age of 30 years [<xref ref-type="bibr" rid="scirp.86642-ref11">11</xref>] .</p><p>For the years 2012 and 2013, Kamangu NE et al. published a carriage of HCV respectively 5.8% and 5.2% of 5271 and 5040 blood bags tested at National Blood Transfusion Center (NBTC) in Kinshasa, a total of 10,311 blood bags for 2 years [<xref ref-type="bibr" rid="scirp.86642-ref12">12</xref>] . The most represented age group in the population was 18 - 30 years old with 82.6% followed by that of 31 - 40 years old with 13.5% and that of 41 - 50 years old with 3.2% [<xref ref-type="bibr" rid="scirp.86642-ref12">12</xref>] . The male dominated the population with 85.8%. Carriage of HCV was twice that of HIV infection under the same conditions [<xref ref-type="bibr" rid="scirp.86642-ref12">12</xref>] .</p><p>Studies presenting the prevalence of hepatitis B and C in the DRC are for the most part conducted in Blood Transfusion Centers (BTC) across the country. There is no study conducted in the general population.</p><p>Through all these different studies, it is clear that the prevalence of hepatitis is always higher than that of HIV in blood donor populations; from 6.4% and 9.2% in 1999 [<xref ref-type="bibr" rid="scirp.86642-ref6">6</xref>] to 3.8% and 5.9% in 2000 [<xref ref-type="bibr" rid="scirp.86642-ref7">7</xref>] respectively for HIV and HBV, or 3.8% and 4.8% in 2000 [<xref ref-type="bibr" rid="scirp.86642-ref7">7</xref>] to 2.1% and 5.2% in 2013 [<xref ref-type="bibr" rid="scirp.86642-ref12">12</xref>] respectively for HIV and HCV specifically in Kinshasa. The prevalence of HBV is always higher than that of HCV in the same populations [<xref ref-type="bibr" rid="scirp.86642-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.86642-ref11">11</xref>] .</p></sec><sec id="s4"><title>4. Conclusion</title><p>Although often asymptomatic, viral hepatitis B and C are a public health problem for the Democratic Republic of Congo. The carriage of these viral infections is far superior to that of HIV infection in Blood Transfusion Centers across the country.</p></sec><sec id="s5"><title>Conflict of Interest</title><p>The authors declare that there is no conflict of interest.</p></sec><sec id="s6"><title>Cite this paper</title><p>Bulanda, B.I., Bongenya, B.I., Kabasele, J.-Y.D., Okonda, M.O., Chuga, D., Tshisumbu, C., Kateba, E.T. and Kamangu, E.N. (2018) Infection with Hepatitis B and C Virus in the Democratic Republic of Congo: A Public Health Problem. Open Access Library Journal, 5: e4760. https://doi.org/10.4236/oalib.1104760</p></sec></body><back><ref-list><title>References</title><ref id="scirp.86642-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Laurain, A., Vallet-Pichard, A., Corouge, M. and Pol, S. (2016) Hépatites Virales. EMC-Maladies Infectieuses. 13, 2.</mixed-citation></ref><ref id="scirp.86642-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Yombi, J.C., Marot, J.C., De Visscher, N., Ausselet, N., Vincent, A. and Vandercam, B. (2007) La co-infection par le Virus de l’Immunodéficience Humaine (VIH) et le Virus de l’Hépatite C (VHC) ou le Virus de l’Hépatite B (VHB). Louvain Médical, 126, 238-245.</mixed-citation></ref><ref id="scirp.86642-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Barth, R.E., Huijgen, Q., Taljaard, J. and Hoepelman, A.I.M. (2010) Hepatitis B/C and HIV in Sub-Saharan Africa: An Association between Highly Prevalent Infectious Diseases. A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases, 14, e1024-e1031. https://doi.org/10.1016/j.ijid.2010.06.013</mixed-citation></ref><ref id="scirp.86642-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Wright, T.L. and Lau, J.Y. (1993) Clinical Aspects of Hepatitis B Virus Infection. The Lancet, 342, 1340-1344. https://doi.org/10.1016/0140-6736(93)92250-W</mixed-citation></ref><ref id="scirp.86642-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Seef, L.B., Buskell-Bales, Z., Wright, E.C., Durako, S.J., Alter, H.J. and Iber, F.L. (1992) Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis. The National Heart, Lung, and Blood Institute Study Group, The New England Journal of Medicine, 332, 1906-1911. https://doi.org/10.1056/NEJM199212313272703</mixed-citation></ref><ref id="scirp.86642-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Mbendi, N.C., Longo-Mbenza, B., Mbendi, N.S., Muyembe, J.J., Situakibanza, N.H. and Vangu, N.D. (2001) Prévalence du VIH et de l’Antigène HBs chez les receveurs de sang à Kinshasa-Est, République Démocratique du Congo. Médecine Tropicale, 61, 139-142.</mixed-citation></ref><ref id="scirp.86642-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Baleka, F., Pukuta, E., Lay, Y., Mwema, G., Mumba, M. and Muyembe, T.J.J. (2014) Prévalence et co-infection de VIH, VHC et VHB chez les donneurs de sang à Kinshasa, RDC. Congo Sciences, 2, 37-40.</mixed-citation></ref><ref id="scirp.86642-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Laurent, C., Henzel, D., Mulanga-Kabeya, C., Maertens, G., Larouze, B. and Delaporte, E. (2001) Seroepidemiological Survey of Hepatitis C Virus among Commercial Sex Workers and Pregnant Women in Kinshasa, Democratic Republic of Congo. International Journal of Epidemiology, 30, 872-877. https://doi.org/10.1093/ije/30.4.872</mixed-citation></ref><ref id="scirp.86642-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Batina, A., Kabemba, S. and Malengela, R. (2007) Marqueurs infectieux chez les donneurs de sang en République Démocratique du Congo (RDC). Revue medicale de Bruxelles, 28, 145-149.</mixed-citation></ref><ref id="scirp.86642-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kabinda, J.M and Katchunga, B.P. (2010) Les Hépatites virales B et C chez les porteurs du Virus de l’Immunodépression Humaine à Bukavu (Sud-Kivu), République Démocratique du Congo. Journal Africain d’Hépato-Gastroentérologie, 4, 230-235.</mixed-citation></ref><ref id="scirp.86642-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kabinda, J.M., Miyanga, S.A., Misingi, P. and Ramazani, S.Y. (2014) Les hépatites B et C chez les donneurs bénévoles de sang et non rémunérés de l’Est de la République Démocratique du Congo. Transfusion Clinique et Biologique, 21, 111-115. https://doi.org/10.1016/j.tracli.2014.04.001</mixed-citation></ref><ref id="scirp.86642-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kamangu, N.E., Nseka, K.N., Ndombasi, M.A. and Mvumbi, L.G. (2016) Séroprévalence de la co-infection VIH-VHC chez les donneurs de sang au Centre National de Transfusion Sanguine à Kinshasa. Proceeding of 8ème Conférence Internationale Francophone-AFRAVIH 2016, Bruxelles, 20-23 April 2006, 375.</mixed-citation></ref></ref-list></back></article>